|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.73 USD | 0.00% |
|
+6.49% | +0.51% |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 33.3 | +87.84% | 12 | ||||||
| 833.31 | +35.56% | 28 | ||||||
| 288.95 | +15.58% | 19 | ||||||
| 2,096,122.22 | +57.25% | 23 | ||||||
| 96.81 | +28.81% | 16 | ||||||
| 220.13 | +12.53% | 30 | ||||||
| 43.3 | -21.84% | 20 | ||||||
| 109.09 | +9.36% | 23 | ||||||
| 101.64 | +53.83% | 26 | ||||||
| 471.67 | +9.59% | 12 | ||||||
| 102.28 | +53.48% | 23 | ||||||
| 275.28 | +9.28% | 21 | ||||||
| 464,000 | +31.63% | 5 | ||||||
| 87.85 | +59.37% | 26 | ||||||
| 328.44 | +1.57% | 9 | ||||||
| 14.52 | +60.45% | 12 | ||||||
| 31.4 | +120.78% | 10 | ||||||
| - | - | 40.3 | +39.45% | 1 | ||||
| - | - | 89.17 | +61.6% | 1 | ||||
| 71.1 | -16.3% | 10 | ||||||
| Average | 128,168.04 | +35.49% | 16 | ||||||
| Weighted average by Cap. | 237,131.18 | +28.71% | 21 |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
